Jin-Long Chen founded NGM Biopharmaceuticals, Inc. Presently, he is Director & Chief Scientific Officer at this company. Dr. Chen is also on the board of Tenaya Therapeutics, Inc.
Dr. Chen previously occupied the position of Vice President-Research at Amgen, Inc. and Vice President-Biology at Tularik, Inc. (a subsidiary of Amgen, Inc.).
Dr. Chen received an undergraduate degree from Fu Jen Catholic University, a graduate degree from National Taiwan University and a doctorate from the University of California, Berkeley.